Notch signaling pathway in osteogenesis, bone development, metabolism, and diseases

Abstract The skeletal system provides vital importance to support organ development and functions. The Notch signaling pathway possesses well‐established functions in organ development and cellular homeostasis. The Notch signaling pathway comprises five typical ligands ( JAG1 , JAG2, DLL1, DLL3, and DLL4), four receptors ( Notch 1‐4), and four intracellular domains (NICD1‐4). Each component of the Notch signaling pathway has been demonstrated to be fundamental in osteoblast differentiation and bone formation. The dysregulation in the Notch signaling pathway is highly linked with skeletal disorders or diseases at the developmental and postnatal stages. Recent studies have highlighted the importance of the elements of the Notch signaling pathway in the skeletal system, as well as its interaction with signaling, such as Wnt/β‐catenin, BMP, TGF‐β, FGF, autophagy, and hedgehog (Hh) to construct a potential gene regulatory network to orchestrate osteogenesis and ossification. Our review has provided a comprehensive summary of the Notch signaling pathway in the skeletal system, as well as the insights targeting Notch signaling for innovative potential drug discovery targets or therapeutic interventions to treat bone disorders, such as osteoporosis and osteoarthritis. An in‐depth molecular mechanistic strategy to modulate the Notch signaling pathway and its associated signaling pathway will be encouraged for consideration to trigger enhanced therapeutic approaches for bone disorders by defining Notch‐regulating drugs for clinical use.